Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial
2023 · Nature Communications · 31 citations
https://doi.org/10.1038/s41467-023-42400-5
M
Maria Pouyiourou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
19
Papers
108
Citations
5
h-index
4
i10-index
Maria Pouyiourou is an academic researcher from German Cancer Research Center. The author has contributed to research in topics: Cancer Diagnosis and Treatment & Tumors and Oncological Cases & Oral and Maxillofacial Pathology. The author has an h-index of 5, co-authored 17 publications.
ORCID: 0000-0001-9296-3784Papers by this author
works185P Multi-omics profiling and clinical characterization of colon-like cancer of unknown primary (CUP)
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.08.2190
3032eP Tissue-specific effects of BAP1 loss on metastatic properties of tumor cell lines
2025 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2025.08.3647
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat